DUBLIN--(BUSINESS WIRE)--The "Auto Transfusion Devices Market - Forecasts From 2018 to 2023" report has been added to ResearchAndMarkets.com's offering.
The Auto transfusion Devices market was valued at US$1.554 billion in 2017 and is projected to grow at a CAGR of 5.83% over the forecast period to reach US$2.182 billion in 2023.
Rising prevalence of cardiovascular diseases around the globe is considered as one of the key factors for driving the growth of the market. According to World Health Organization nearly 17.9 million people die every year due to CVDs which is around 31% of all deaths worldwide.
Auto transfusion devices are getting high acceptance on account of benefits such as it reduces the risk of transmission of infectious diseases and no danger of isosensitization. Moreover increasing investment in health care sector in the developing countries is also expected to propel the growth of the auto transfusion market.
Major industry players profiled as part of the report are Medline, Medtronic, Haemonetics, Fresenius Kabi and Terumo Corporation among others.
Key Topics Covered
1. INTRODUCTION
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
5. AUTO TRANSFUSION DEVICES MARKET BY APPLICATION
5.1. Cardiac Vascular
5.2. Orthopedic
5.3. Liver Transplantation
5.4. Others
6. AUTO TRANSFUSION DEVICES MARKET BY END-USER
6.1. Hospitals
6.2. Ambulatory Surgery Centers
7. AUTO TRANSFUSION DEVICES MARKET BY GEOGRAPHY
8. COMPETITIVE INTELLIGENCE
8.1. Market Share Analysis
8.2. Recent Investment and Deals
8.3. Strategies of Key Players
9. COMPANY PROFILES
9.1. Medline
9.2. Medtronic
9.3. Haemonetics
9.4. Fresenius Kabi
9.5. Terumo Corporation
9.6. LivaNova
9.7. Atrium Medical
9.8. Redax
9.9. Sarstedt
For more information about this report visit https://www.researchandmarkets.com/research/n8hwqx/the_global_auto?w=4
